BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Genetown

  Verastem Oncology to Participate in Upcoming Investor Conferences

  Verastem Oncology today announced that the Company will participate in the following upcoming investor conferences.

  May 1, 2023

   · 

  1 min read
• Biotech Beach

  Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting

  Glaukos Corporation announced today that its technologies will be featured in various scientific programming at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, being held May 5 – 8, 2023 in San Diego, CA.

  May 1, 2023

   · 

  8 min read
• Bausch + Lomb Releases Annual Environmental, Social and Governance Report

  Bausch + Lomb Corporation, today released its annual Environmental, Social and Governance (ESG) Report, highlighting the Company’s ongoing commitment to implement sustainable business practices and initiatives that support its stakeholders’ well-being.

  May 1, 2023

   · 

  4 min read
• Biotech Bay

  AN2 Therapeutics to Present at JMP Securities Life Sciences Conference

  AN2 Therapeutics, Inc. today announced that Eric Easom, Co-Founder, President and CEO, will present at the JMP Securities Life Sciences Conference.

  May 1, 2023

   · 

  1 min read
• Pharm Country

  Bristol Myers Squibb’s TRANSCEND FL and TRANSCEND NHL 001 Studies of Breyanzi in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma Meet Primary Endpoint of Overall Response Rate

  Bristol Myers Squibb’s TRANSCEND FL and TRANSCEND NHL 001 Studies of Breyanzi (lisocabtagene maraleucel) in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma Meet Primary Endpoint of Overall Response Rate.

  May 1, 2023

   · 

  17 min read
• Genetown

  AlloVir to Present at the BofA Securities 2023 Health Care Conference

  AlloVir, Inc. announced today that Diana Brainard, M.D., Chief Executive Officer, will participate in a fireside chat at the BofA Securities 2023 Health Care Conference in Las Vegas, NV on Tuesday, May 9, 2023, at 8:40 a.m. PDT.

  May 1, 2023

   · 

  1 min read
• Business

  2seventy bio and Novo Nordisk Collaboration Delivers Key Proof of Concept Data, Triggering $15 Million Preclinical Milestone in In Vivo Gene Editing Hemophilia A Program

  2seventy bio and Novo Nordisk Collaboration Delivers Key Proof of Concept Data, Triggering $15 Million Preclinical Milestone in In Vivo Gene Editing Hemophilia A Program.

  May 1, 2023

   · 

  6 min read
• Business

  Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights

  Envision Pharma Group (Envision) has appointed Tino Quintero to the role of General Manager/VP of Market Access & Customer Insights.

  May 1, 2023

   · 

  2 min read
• Genetown

  Intellia Therapeutics Releases 2023 Corporate Responsibility Report Highlighting the Advancement of its Environmental, Social & Governance (ESG) Priorities

  Intellia Therapeutics, Inc. today released its 2023 Corporate Responsibility report.

  May 1, 2023

   · 

  5 min read
• Business

  Cognition Therapeutics Appoints John Doyle to the Role of Chief Financial Officer

  Cognition Therapeutics, Inc. (Nasdaq: CGTX), today announced the appointment of John Doyle to the role of chief financial officer.

  May 1, 2023

   · 

  5 min read